- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 4 residues within 4Å:- Chain A: N.110, S.111, S.112, H.114
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.4: 4 residues within 4Å:- Chain B: N.110, S.111, S.112, H.114
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.6: 4 residues within 4Å:- Chain C: N.110, S.111, S.112, H.114
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.8: 4 residues within 4Å:- Chain D: N.110, S.111, S.112, H.114
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.10: 4 residues within 4Å:- Chain E: N.110, S.111, S.112, H.114
No protein-ligand interaction detected (PLIP)- 10 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.11: 17 residues within 4Å:- Chain A: Y.128, D.130, R.132, D.265, S.266, V.267, Q.272, A.275, I.279
- Chain B: L.208, L.212, I.216, V.219, L.220, D.548, F.549
- Ligands: YLI.16
9 PLIP interactions:6 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:V.267, A:V.267, A:V.267, B:L.208, B:I.216, B:F.549
- Hydrogen bonds: A:V.267
- Salt bridges: A:D.130, A:R.132
POV.15: 19 residues within 4Å:- Chain A: L.220, A.223, L.224, L.226, L.227, L.230, R.321, M.322, R.517, L.520, S.524
- Chain E: M.278, I.279, G.282, L.283, V.286, I.290, Q.293
- Ligands: YLI.14
10 PLIP interactions:6 interactions with chain A, 4 interactions with chain E- Hydrophobic interactions: A:A.223, A:L.224, A:L.227, A:L.230, A:L.520, E:L.283, E:V.286, E:V.286
- Hydrogen bonds: A:R.517, E:Q.293
POV.17: 19 residues within 4Å:- Chain A: M.278, I.279, G.282, L.283, V.286, I.290, Q.293
- Chain B: L.220, A.223, L.224, L.226, L.227, L.230, R.321, M.322, R.517, L.520, S.524
- Ligands: YLI.16
10 PLIP interactions:6 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:A.223, B:L.224, B:L.227, B:L.230, B:L.520, A:L.283, A:V.286, A:V.286
- Hydrogen bonds: B:R.517, A:Q.293
POV.18: 17 residues within 4Å:- Chain B: Y.128, D.130, R.132, D.265, S.266, V.267, Q.272, A.275, I.279
- Chain C: L.208, L.212, I.216, V.219, L.220, D.548, F.549
- Ligands: YLI.21
9 PLIP interactions:3 interactions with chain C, 6 interactions with chain B- Hydrophobic interactions: C:L.208, C:I.216, C:F.549, B:V.267, B:V.267, B:V.267
- Hydrogen bonds: B:V.267
- Salt bridges: B:D.130, B:R.132
POV.22: 19 residues within 4Å:- Chain B: M.278, I.279, G.282, L.283, V.286, I.290, Q.293
- Chain C: L.220, A.223, L.224, L.226, L.227, L.230, R.321, M.322, R.517, L.520, S.524
- Ligands: YLI.21
10 PLIP interactions:6 interactions with chain C, 4 interactions with chain B- Hydrophobic interactions: C:A.223, C:L.224, C:L.227, C:L.230, C:L.520, B:L.283, B:V.286, B:V.286
- Hydrogen bonds: C:R.517, B:Q.293
POV.23: 17 residues within 4Å:- Chain C: Y.128, D.130, R.132, D.265, S.266, V.267, Q.272, A.275, I.279
- Chain D: L.208, L.212, I.216, V.219, L.220, D.548, F.549
- Ligands: YLI.26
9 PLIP interactions:6 interactions with chain C, 3 interactions with chain D- Hydrophobic interactions: C:V.267, C:V.267, C:V.267, D:L.208, D:I.216, D:F.549
- Hydrogen bonds: C:V.267
- Salt bridges: C:D.130, C:R.132
POV.27: 19 residues within 4Å:- Chain C: M.278, I.279, G.282, L.283, V.286, I.290, Q.293
- Chain D: L.220, A.223, L.224, L.226, L.227, L.230, R.321, M.322, R.517, L.520, S.524
- Ligands: YLI.26
10 PLIP interactions:4 interactions with chain C, 6 interactions with chain D- Hydrophobic interactions: C:L.283, C:V.286, C:V.286, D:A.223, D:L.224, D:L.227, D:L.230, D:L.520
- Hydrogen bonds: C:Q.293, D:R.517
POV.28: 17 residues within 4Å:- Chain D: Y.128, D.130, R.132, D.265, S.266, V.267, Q.272, A.275, I.279
- Chain E: L.208, L.212, I.216, V.219, L.220, D.548, F.549
- Ligands: YLI.31
9 PLIP interactions:6 interactions with chain D, 3 interactions with chain E- Hydrophobic interactions: D:V.267, D:V.267, D:V.267, E:L.208, E:I.216, E:F.549
- Hydrogen bonds: D:V.267
- Salt bridges: D:D.130, D:R.132
POV.32: 19 residues within 4Å:- Chain D: M.278, I.279, G.282, L.283, V.286, I.290, Q.293
- Chain E: L.220, A.223, L.224, L.226, L.227, L.230, R.321, M.322, R.517, L.520, S.524
- Ligands: YLI.31
10 PLIP interactions:6 interactions with chain E, 4 interactions with chain D- Hydrophobic interactions: E:A.223, E:L.224, E:L.227, E:L.230, E:L.520, D:L.283, D:V.286, D:V.286
- Hydrogen bonds: E:R.517, D:Q.293
POV.33: 17 residues within 4Å:- Chain A: L.208, L.212, I.216, V.219, L.220, D.548, F.549
- Chain E: Y.128, D.130, R.132, D.265, S.266, V.267, Q.272, A.275, I.279
- Ligands: YLI.14
9 PLIP interactions:6 interactions with chain E, 3 interactions with chain A- Hydrophobic interactions: E:V.267, E:V.267, E:V.267, A:L.208, A:I.216, A:F.549
- Hydrogen bonds: E:V.267
- Salt bridges: E:D.130, E:R.132
- 5 x 9Z9: (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en(Non-covalent)
9Z9.12: 10 residues within 4Å:- Chain A: W.315, C.316, W.318, F.319, L.320, L.518, M.521, A.522, V.525, F.526
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:W.315, A:F.319, A:F.319, A:F.319, A:M.521, A:A.522, A:V.525, A:V.525
9Z9.19: 10 residues within 4Å:- Chain B: W.315, C.316, W.318, F.319, L.320, L.518, M.521, A.522, V.525, F.526
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:W.315, B:F.319, B:F.319, B:F.319, B:M.521, B:A.522, B:V.525, B:V.525
9Z9.24: 10 residues within 4Å:- Chain C: W.315, C.316, W.318, F.319, L.320, L.518, M.521, A.522, V.525, F.526
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:W.315, C:F.319, C:F.319, C:F.319, C:M.521, C:A.522, C:V.525, C:V.525
9Z9.29: 10 residues within 4Å:- Chain D: W.315, C.316, W.318, F.319, L.320, L.518, M.521, A.522, V.525, F.526
8 PLIP interactions:8 interactions with chain D- Hydrophobic interactions: D:W.315, D:F.319, D:F.319, D:F.319, D:M.521, D:A.522, D:V.525, D:V.525
9Z9.34: 10 residues within 4Å:- Chain E: W.315, C.316, W.318, F.319, L.320, L.518, M.521, A.522, V.525, F.526
8 PLIP interactions:8 interactions with chain E- Hydrophobic interactions: E:W.315, E:F.319, E:F.319, E:F.319, E:M.521, E:A.522, E:V.525, E:V.525
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.13: 3 residues within 4Å:- Chain A: N.67, S.69, E.70
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:E.70
NAG.20: 3 residues within 4Å:- Chain B: N.67, S.69, E.70
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.70
NAG.25: 3 residues within 4Å:- Chain C: N.67, S.69, E.70
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:E.70
NAG.30: 3 residues within 4Å:- Chain D: N.67, S.69, E.70
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:E.70
NAG.35: 3 residues within 4Å:- Chain E: N.67, S.69, E.70
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:E.70
- 5 x YLI: (3aR,4S,9bS)-4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide(Non-covalent)
YLI.14: 18 residues within 4Å:- Chain A: L.212, N.213, I.216, P.217, L.220, I.221, L.224
- Chain E: L.246, M.253, M.260, A.271, F.274, A.275, M.278, I.279, G.282
- Ligands: POV.15, POV.33
8 PLIP interactions:3 interactions with chain E, 5 interactions with chain A- Hydrophobic interactions: E:A.275, E:M.278, E:I.279, A:I.216, A:P.217, A:L.220, A:L.220, A:I.221
YLI.16: 18 residues within 4Å:- Chain A: L.246, M.253, M.260, A.271, F.274, A.275, M.278, I.279, G.282
- Chain B: L.212, N.213, I.216, P.217, L.220, I.221, L.224
- Ligands: POV.11, POV.17
8 PLIP interactions:3 interactions with chain A, 5 interactions with chain B- Hydrophobic interactions: A:A.275, A:M.278, A:I.279, B:I.216, B:P.217, B:L.220, B:L.220, B:I.221
YLI.21: 18 residues within 4Å:- Chain B: L.246, M.253, M.260, A.271, F.274, A.275, M.278, I.279, G.282
- Chain C: L.212, N.213, I.216, P.217, L.220, I.221, L.224
- Ligands: POV.18, POV.22
8 PLIP interactions:5 interactions with chain C, 3 interactions with chain B- Hydrophobic interactions: C:I.216, C:P.217, C:L.220, C:L.220, C:I.221, B:A.275, B:M.278, B:I.279
YLI.26: 18 residues within 4Å:- Chain C: L.246, M.253, M.260, A.271, F.274, A.275, M.278, I.279, G.282
- Chain D: L.212, N.213, I.216, P.217, L.220, I.221, L.224
- Ligands: POV.23, POV.27
8 PLIP interactions:3 interactions with chain C, 5 interactions with chain D- Hydrophobic interactions: C:A.275, C:M.278, C:I.279, D:I.216, D:P.217, D:L.220, D:L.220, D:I.221
YLI.31: 18 residues within 4Å:- Chain D: L.246, M.253, M.260, A.271, F.274, A.275, M.278, I.279, G.282
- Chain E: L.212, N.213, I.216, P.217, L.220, I.221, L.224
- Ligands: POV.28, POV.32
8 PLIP interactions:3 interactions with chain D, 5 interactions with chain E- Hydrophobic interactions: D:A.275, D:M.278, D:I.279, E:I.216, E:P.217, E:L.220, E:L.220, E:I.221
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Burke, S.M. et al., Structural mechanisms of alpha 7 nicotinic receptor allosteric modulation and activation. Cell (2024)
- Release Date
- 2024-02-21
- Peptides
- Neuronal acetylcholine receptor subunit alpha-7,Soluble cytochrome b562: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 10 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 5 x 9Z9: (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en(Non-covalent)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x YLI: (3aR,4S,9bS)-4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Burke, S.M. et al., Structural mechanisms of alpha 7 nicotinic receptor allosteric modulation and activation. Cell (2024)
- Release Date
- 2024-02-21
- Peptides
- Neuronal acetylcholine receptor subunit alpha-7,Soluble cytochrome b562: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.